List all clinical trials by discovery date. Accepts regular expressions in search.

GET /trials/?page=71
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 802,
    "next": "http://api.gregory-ms.com/trials/?page=72",
    "previous": "http://api.gregory-ms.com/trials/?page=70",
    "results": [
        {
            "trial_id": 102,
            "title": "Tele-Assessment and Face-to-Face Evaluation of Functional Gait Assessment in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    <br/><b>Sponsor</b>:    Istanbul University-Cerrahpasa<br/><b>Recruiting</b>",
            "published_date": "2021-06-21T16:00:00Z",
            "discovery_date": "2021-06-21T20:04:49Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04932616?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 101,
            "title": "Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Other: Siponimod<br/><b>Sponsor</b>:    Novartis Pharmaceuticals<br/><b>Not yet recruiting</b>",
            "published_date": "2021-06-21T16:00:00Z",
            "discovery_date": "2021-06-21T20:04:49Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04933552?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 103,
            "title": "Investigation of Hand Functions and Related Parameters in People With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    <br/><b>Sponsors</b>:    Uğur OVACIK;   Istanbul University-Cerrahpasa<br/><b>Not yet recruiting</b>",
            "published_date": "2021-06-21T16:00:00Z",
            "discovery_date": "2021-06-21T20:04:49Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04933110?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 98,
            "title": "The Gut Microbiome in Adult Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    <br/><b>Sponsor</b>:    National MS Center Melsbroek<br/><b>Completed</b>",
            "published_date": "2021-06-17T16:00:00Z",
            "discovery_date": "2021-06-18T22:15:49Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04929145?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 100,
            "title": "Feasibility of Neuromodulation With Connectivity-Guided iTBS for Cognitive Impairment in MS",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Cognitive Impairment<br/><b>Interventions</b>:    Other: Intermittent theta burst stimulation (iTBS);   Other: Sham Intermittent theta burst stimulation (iTBS)<br/><b>Sponsor</b>:    University of Nottingham<br/><b>Not yet recruiting</b>",
            "published_date": "2021-06-18T16:00:00Z",
            "discovery_date": "2021-06-18T22:15:49Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04931953?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 99,
            "title": "Description of Adherence to the Main Preventive Health Campaigns of Persons With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Other: phone interview<br/><b>Sponsor</b>:    University of Siena<br/><b>Recruiting</b>",
            "published_date": "2021-06-18T16:00:00Z",
            "discovery_date": "2021-06-18T22:15:49Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04930380?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 96,
            "title": "Safety and Effectiveness of Cinnomer® (Glatiramer Acetate) in Multiple Sclerosis (MS) Treatment in Iran",
            "summary": "<b>Condition</b>:    Relapsing Multiple Sclerosis<br/><b>Intervention</b>:    Drug: Glatiramer Acetate<br/><b>Sponsor</b>:    Cinnagen<br/><b>Completed</b>",
            "published_date": "2021-06-16T16:00:00Z",
            "discovery_date": "2021-06-16T18:08:49Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04928313?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 97,
            "title": "Multiple Sclerosis and Voiding Symptoms: How to Assess?",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Lower Urinary Tract Symptoms;   Voiding Disorders<br/><b>Intervention</b>:    Other: voiding phase evaluation<br/><b>Sponsor</b>:    Pierre and Marie Curie University<br/><b>Completed</b>",
            "published_date": "2021-06-16T16:00:00Z",
            "discovery_date": "2021-06-16T18:08:49Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04928716?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 95,
            "title": "Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis (MS)<br/><b>Interventions</b>:    Drug: Fingolimod;   Drug: Ofatumumab;   Drug: Siponimod;   Other: Fingolimod placebo;   Other: Siponimod placebo;   Other: Ofatumumab placebo<br/><b>Sponsor</b>:    Novartis Pharmaceuticals<br/><b>Not yet recruiting</b>",
            "published_date": "2021-06-15T16:00:00Z",
            "discovery_date": "2021-06-15T16:34:48Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04926818?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 94,
            "title": "Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Secondary-progressive Multiple Sclerosis<br/><b>Interventions</b>:    Drug: Mayzent;   Drug: Ocrevus<br/><b>Sponsor</b>:    Robert Zivadinov, MD, PhD<br/><b>Not yet recruiting</b>",
            "published_date": "2021-06-14T16:00:00Z",
            "discovery_date": "2021-06-14T17:57:48Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04925557?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        }
    ]
}